Summary
In patients with probable Alzheimer's disease and in controls, acetyl- and butyrylcholinesterase activities were studied in cerebrospinal fluid (CSF) and plasma, and acetylcholinesterase activity of erythrocytes was determined. In addition, the molecular forms of acetylcholinesterase were measured in CSF. Severely demented patients had significantly lower acetylcholinesterase (p<0.01) and butyrylcholinesterase (p<0.05) activities in CSF than the controls had, but the activities of these enzymes in plasma and erythrocytes were within the same range in both groups. Acetylcholinesterase and butyrylcholinesterase activities in the CSF of mildly demented patients did not differ from control values. The ratio of the intermediate molecular form of acetylcholinesterase to the light molecular form of the enzyme did not differ significantly between patients with Alzheimer's disease and controls. According to our results, AChE levels were lower in the CSF of severely demented patients, but both light and intermediate molecular forms were affected.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adem A, Nordberg A, Bucht G, Winblad B (1986) Extraneural cholinergic markers in Alzheimer's and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 10: 274–257
Arendt T, Bigl V, Walther F, Sonntag M (1984) Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease. Lancet 1: 173
Atack JR, Perry EK, Perry RH, Tomlinson BE, Blessed G, Fairbarn A (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer-type: selective loss of intermediate 10 S form. Neurosci Lett 40: 199–204
Atack JR, Perry EK, Perry RH, Wilson ID, Bober MJ, Blessed G, Tomlinson BE (1985) Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type. J Neurol Sci 70: 1–12
Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH (1986) Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem 47: 263–277
Bareggi SR, Giacobini E (1978) Acetylcholinesterase activity in ventricular and cisternal CSF of dogs: effect of chlorpromazine. J Neurosci Res 3: 335–229
Bisso GM, Masullo C, Michalek H, Silveri MC, Pocchiari M (1986) Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls. Life Sci 38: 561–567
Brimijoin S (1983) Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Prog Neurobiol 21: 291–322
Davies P (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171: 319–327
Elble R, Giacobini E, Scarsella GF (1987) Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer's disease. Arch Neurol 44: 403–407
Ellman GL, Courtney DK, Anders V Jr, Feartherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95
Festoff BW, Fernandez HL (1981) Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis. Muscle Nerve 4: 41–47
Fishman EB, Siek GC, MacCallum RD, Bird ED, Volicer L, Marquis JK (1986) Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann Neurol 19: 246–252
Hollander E, Mohs RC, Davis KL (1986) Antemortem markers of Alzheimer's disease. Neurobiol Aging 7: 367–387
Huff FJ, Maire JC, Growdon JH, Corkin S, Wurtman RJ (1986) Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease. J Neurol Sci 72: 121–129
Hughes CP, Berg L, Danziger WL, Coben LA (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572
Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V, Laakso M, Riekkinen P (1986) Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. J Neurol Neurosurg Psychiatry 49: 1374–1377
Katzman R (1986) Alzheimer's disease. N Engl J Med 314: 964–973
Lal SPL, Wood PL, Kiely ME, Etinne P, Gauther S, Stratford J, Ford RM, Dastoor D, Nair NPV (1984) CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF. Neurobiol Aging 5: 269–274
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Marquis JK, Volicer L, Mark KA, Direnfeld LK, Freedman M (1985) Cholinesterase activity in plasma, erythrocytes and cerebrospinal fluid of patients with dementia of the Alzheimer type. Biol Psychiatry 20: 605–610
McKhann G, Drachman D, Folstein M, Price M, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under auspices of the department of health and human services task force on Alzheimer's disease. Neurology 34: 939–944
Nakano S, Kato T, Nakamura S, Kameyama M (1986) Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia. J Neurol Sci 75: 213–223
Reinikainen K, Soininen H, Kosma V-M, Halonen T, Jolkkonen J, Riekkinen PJ (1985) Neurotransmitters in senile dementia of Alzheimer type and in vascular dementia. Interdiscipl Top Gerontol 19: 184–197
Riekkinen PJ, Soininen H, Sirviö J, Reinikainen K, Helkala E-L, Paljärvi L (1987) Dementia without cholinergic deficit. Gerontology 33: 268–272
Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7: 486–488
Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984) Neurochemcial characteristics of early and late onset types of Alzheimer's disease. Br Med J 288: 961–964
Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AW (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40: 503–509
Sirviö J, Soininen HS, Kutvonen R, Hyttinen J-M, Helkala E-L, Riekkinen PJ (1987) Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 81: 273–279
Soininen HS, Jolkkonen JT, Reinikainen KJ, Halonen TO, Riekkinen PJ (1984) Reduced cholinesterase and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of Alzheimer type. J Neurol Sci 63: 167–172
Tune L, Gucker S, Folstein M, Oshida L, Coyle JT (1985) Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type. Ann Neurol 17: 46–48
Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, Price DL (1985) Alzheimer's disease and related dementias selective involvement of specific neuronal systems. C R Clin Neurobiol 1: 319–339
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sirviö, J., Kutvonen, R., Soininen, H. et al. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease. J. Neural Transmission 75, 119–127 (1989). https://doi.org/10.1007/BF01677425
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01677425